Fundz

Radiant reported raising $34.3 Million in an initial SEC Form D filing, from an offering of $34.3 Million

PRIVATEOct 01, 2024

Amount Raised

$34.3 Million

$34.3 Million per company press release (Nov 14, 2024)

Round Type

Venture

TorontoBiotechnologyHealth CareTherapeutics

Quick answer

Radiant raised $34.3 Million in a funding round, dated August 27, 2024. Radiant is based in Toronto, Ontario, Canada.

How much did Radiant raise?
Radiant raised $34.3 Million in a funding round on August 27, 2024.
What does Radiant do?
Radiant Biotherapeutics is a revolutionary antibody platform company leading the new frontier of multi-valent, multi-specific therapeutics to deliver transformative therapies for patients.
Where is Radiant based and how big is it?
Radiant is based in Toronto, Ontario, Canada.
Who are the decision-makers at Radiant?
Fundz holds 1 contact at Radiant. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Radiant, and when

A new round usually means Radiant is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Radiant raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Radiant, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Radiant. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Radiant

Location

Toronto, Ontario, Canada

About

Radiant Biotherapeutics is a revolutionary antibody platform company leading the new frontier of multi-valent, multi-specific therapeutics to deliver transformative therapies for patients. The proprietary Multabody platform leverages avidity and multi-specificity simultaneously, to generate highly efficacious Multabodies with superior potency than other antibody platforms. These powerful Multabodies have potential to deliver a new class of biologics to tackle complex, heterogenous diseases, such as cancer, that often have challenging targets and mechanisms. Multabody production and manufacturing is flexible, modular and scalable, and leverages standard antibody CMC processes. The groundbreaking efficiency of the platform is driving a novel pipeline of mono-, bi- and tri-specific biologics in multiple therapeutics areas. Strategic partnerships with two leading biopharmaceutical companies validate the platform and its broad scientific and clinical utility.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Radiant raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Radiant's next move

See what Strategic adds

Radiant raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.